Age-Related Macular Degeneration Market Epidemiology Report 2025-2035: Drugs Pipeline, Therapies, and Forecast The report provides a detail ...

Paris: Sanofi has received fast track designation from the US Food and Drug Administration (FDA) for SAR446597, a one-time ...

Canadian study reveals diabetic patients taking GLP-1 medications face twice the risk of eye problems, with longer exposure increasing danger of macular degeneration.

Sanofi’s SAR446597 earns fast track designation in the US for geographic atrophy due to age-related macular degeneration Designation earned for a one-time intravitreal gene therapy designed to inhibit ...

One of the two most common drugs used to treat age-related macular degeneration (AMD) appears better than the other, a new, small study suggests. Among 106 patients with "wet" age-related macular ...

Here's what macular degeneration is, what causes it and how you can expect it to be treated if it affects you or a loved one.

New Drug Available For Treatment Of "Wet" Macular Degeneration Disease. ScienceDaily . Retrieved June 4, 2025 from www.sciencedaily.com / releases / 2005 / 02 / 050212191023.htm ...

Other big drug makers, including Roche, Novartis, and Genetech, are also marketing or working on treatments for macular degeneration. Founded in 1987 as a private company, EyePoint went public in ...

Scientists have found that an existing drug, already used in humans, could help restore vision lost to conditions like age-related macular degeneration and retinitis pigmentosa. The discovery ...

NEW YORK, March 1 (UPI) --Age-related macular degeneration remains a leading cause of vision loss in the United States, but new advancements could help manage and, in some cases, prevent its ...

Age-related macular degeneration (AMD) is most likely to affect people over the age of 50 and occurs due to the aging process. However, macular degeneration can affect a person in their twenties ...

If you suffer from the ‘‘wet'' form of macular degeneration, a new drug may offer hope of saving your eyesight, according to a new study. Skip to main content Skip to main content ...